Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

28.26
Delayed Data
As of Dec 02
 +1.26 / +4.67%
Today’s Change
3.04
Today|||52-Week Range
30.98
+183.17%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 35.00, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +23.85% increase from the last price of 28.26.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.82
Sales
$7.3M
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.96%
 
 
 
 
 
 
Growthannually -155.63%
 
 
 
 
 
 

Sales

Growthquarterly 69.27%
 
 
 
 
 
 
Growthannually 587.71%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.